Latest: NOCIL Ltd Q2 FY27 results →All Q1 FY27 results →
N

NOCIL Ltd

Q1 FY27Chemicals & Petrochemicals

NOCIL Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹166
Market cap₹2.8K Cr
P/E39.8
Updated16 Oct 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

NOCIL expects revenue for FY27 to be in the range of Rs 1,400 to Rs 1,600 crores, based on the current pricing environment. Revenue guidance for FY27 is projected between Rs 1,400 to Rs 1,600 crores, reflecting continued growth.

From NOCIL Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Moderate growth
  • NOCIL expects revenue for FY27 to be in the range of Rs 1,400 to Rs 1,600 crores, based on the current pricing environment.
  • The company targets around 10% volume growth for the full year FY27.
  • EBITDA margin is expected to hover around 10% for FY27, supported by volume growth and operating leverage.
  • Export volumes aim to grow from around 33% currently to approximately 40-45% by FY28-29, indicating an increased focus on international markets.
  • Specialty segment, constituting 15% of the current topline, is expected to increase by an additional 5-10%, reaching around 20-25% of total revenue in 1-2 years.

2 more points from NOCIL Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what NOCIL Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • NOCIL is progressing well with a new Rs 130 crore investment in Dahej.
  • The Rs 130 crore investment is on track despite challenges due to the Middle East geopolitical situation.
  • Trial production at the new TDQ plant in Dahej has started, with sample approvals underway.
  • Commercial volumes from the TDQ plant are expected to start trickling in by Q4 FY27 and ramp up more significantly in Q1 FY28.
  • The investment in the TDQ plant aims to reinforce NOCIL's competitive market position.

2 more points from NOCIL Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what NOCIL Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The following points provide some related insights: - The company faced temporary supply-side constraints and logistical challenges in Q1 FY27, causing a moderate 3% sequential volume decline and postponement of certain order commitments (Page 4). - Customer demand remains healthy despite operational issues, and the company is confident of recovering deferred volumes in upcoming quarters (Page 4).

2 more points from NOCIL Ltd's call on order book

Create a free account to keep reading this call

NOCIL Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹427 Cr, net profit ₹24 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Alufluoride Ltd (Q1 FY27)

    Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Devson Catalyst Ltd (Q1 FY27)

    FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

  • Ambani Orgochem (Q1 FY27)

    Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

NOCIL Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were NOCIL Ltd Q1 FY27 results?

NOCIL expects revenue for FY27 to be in the range of Rs 1,400 to Rs 1,600 crores, based on the current pricing environment. Revenue guidance for FY27 is projected between Rs 1,400 to Rs 1,600 crores, reflecting continued growth.

What is NOCIL Ltd share price analysis?

NOCIL Ltd currently shows a below-average growth signal. The stock trades at a P/E of 39.8 with a market cap of ₹2,767 Cr. Investors should review the full earnings analysis for detailed insights.

Is NOCIL Ltd planning capital expenditure?

NOCIL is progressing well with a new Rs 130 crore investment in Dahej.

Keep NOCIL Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.